A Comparative Effectiveness RCT of Optimized Cessation Treatments

NCT02301403 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 623

Last updated 2020-05-13

Study results available
· View outcomes & findings →

Summary

This study is a 2-arm randomized clinical trial (RCT). Participants motivated to quit smoking will be randomized to one of two treatments: 1) a Modern Usual Care (M-UC) vs. 2) Abstinence-Optimized Cessation Treatment (AOCT). The components for the optimized treatment have strong theoretical and empirical support from the investigators previous screening studies.

Conditions

  • Smoking Cessation

Interventions

DRUG

Nicotine patch

8 weeks of nicotine patch

BEHAVIORAL

in-person counseling and quitline counseling

a single brief, in-person counseling session plus a faxed referral to the Wisconsin Tobacco Quit Line (WTQL), for counseling, including the QUITNOW app and the Website

DRUG

Preparation Nicotine Mini-Lozenges

Nicotine lozenge prior to attempting to quit smoking

DRUG

Combination NRT (nicotine patch + nicotine mini-lozenges)

26 weeks of combination NRT as part of a quit smoking attempt

BEHAVIORAL

Intensive In-Person Cessation Counseling

three 20-min In-person Cessation Counseling sessions

BEHAVIORAL

Extended Maintenance Counseling Calls

8 Maintenance-phase smoking cessation counseling sessions

BEHAVIORAL

Automated Adherence Calls

11 brief, automated calls reminding them to use their medications properly

Sponsors & Collaborators

  • Penn State University

    collaborator OTHER
  • University of Illinois at Chicago

    collaborator OTHER
  • University of Wisconsin, Madison

    lead OTHER

Principal Investigators

  • Megan Piper, PhD · University of Wisconsin, Madison

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2015-01-31
Primary Completion
2017-12-31
Completion
2018-02-28

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02301403 on ClinicalTrials.gov